Literature DB >> 3080222

Neurofibromatosis and childhood tumors.

J Blatt, R Jaffe, M Deutsch, J C Adkins.   

Abstract

Although tumors are a known complication of von Recklinghausen's neurofibromatosis (NF), they often develop after the second decade and their characteristics in the pediatric population are unclear. To define the frequency and distribution of tumor types in children with NF, the authors reviewed the experience at Children's Hospital of Pittsburgh between 1953 and 1984. During that time, 121 children younger than 18 years with documented NF were seen. Three patients (2.5%) developed locally extensive, unresectable sarcomas, two of which were clearly neural in origin. Two other children died from complications of highly cellular but not histologically malignant neurofibromas. Seventeen patients (14%) had brain tumors, of which 3 (2.5%) were malignant astrocytomas and 9 were optic gliomas. Two children had acute myelogenous leukemia. Although it has been said that patients with NF are particularly susceptible to the oncogenic effects of radiation, 12 children were treated with a median of 5000 rad to their tumor bed. Follow-up after radiation in that small cohort of patients ranged from 6 months to 12 years (mean, 6 years). Eleven of 12 patients experienced adequate local control. During the follow-up period, none developed a second tumor outside or within the radiation port that could be related to radiation. The authors conclude that clinically significant tumors in children with NF, not all of which are histologically malignant, are not rare. Although more prospective information is needed on response to and sequelae from therapy, the data in this report suggest no contraindication to aggressive therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3080222     DOI: 10.1002/1097-0142(19860315)57:6<1225::aid-cncr2820570627>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.

Authors:  Thomas J Turbyville; Demirkan B Gürsel; Robert G Tuskan; Jessica C Walrath; Claudia A Lipschultz; Stephen J Lockett; David F Wiemer; John A Beutler; Karlyne M Reilly
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

2.  Potential risk factors for brain tumors in children. An analysis of 200 cases.

Authors:  R Giuffrè; G Liccardo; F S Pastore; A Spallone; R Vagnozzi
Journal:  Childs Nerv Syst       Date:  1990-01       Impact factor: 1.475

3.  Glioblastoma in a patient with neurofibromatosis type 1: a case report and review of the literature.

Authors:  Tae-Seok Jeong; Gi-Taek Yee
Journal:  Brain Tumor Res Treat       Date:  2014-04-29

Review 4.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

5.  Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma.

Authors:  Jianqiang Wu; Jason T Crimmins; Kelly R Monk; Jon P Williams; Maureen E Fitzgerald; Susan Tedesco; Nancy Ratner
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Favorable prognosis for brainstem gliomas in neurofibromatosis.

Authors:  J M Milstein; J R Geyer; M S Berger; W A Bleyer
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

Review 7.  Biological aspects of brain tumors in infancy and childhood.

Authors:  R Giuffrè
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

8.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16

9.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

10.  MR imaging characteristics of pilomyxoid astrocytomas.

Authors:  Atilla Arslanoglu; Bayram Cirak; Alena Horska; James Okoh; Tarik Tihan; Leslie Aronson; Anthony M Avellino; Peter C Burger; David M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.